Searchable abstracts of presentations at key conferences in endocrinology

ea0073aep822 | Late Breaking | ECE2021

Influence of physician-related factors on the “Glycemic Happiness” of persons with T2DM: Interim analysis of an observational survey

Kalra Sanjay , Kumar Das Ashok , Priya Gagan , Krishna Polavarapu Nareen , Gaurav Kumar , Mane Amey , Stephen Pinto Colette

BackgroundApart from long-term complications associated with diabetes(T2DM), the psychological impact also significantly contributes to poor outcomes in persons living with diabetes. An observational survey was undertaken to assess various physician-related factors that can help define “glycemic happiness” for persons living with T2DM.MethodsA prospective, multicentric, cross sectional, observationa...

ea0099p299 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Effectiveness of dapagliflozin and sitagliptin fixed dose combination in indian patients with type 2 diabetes mellitus in real world settings: age stratified-analysis from a retrospective study

Agrawala Ritesh , Bhattacharyya Supratik , Bharathi B Prakadeesh , Kudrigikar Vinay , Ahire Prachi , Dharmadhikari Shruti , Khandhedia Chintan , Markandeywar Neeraj , Mane Amey , Mehta Suyog

Introduction and Objective: Incidence of type 2 diabetes mellitus (T2D) is rapidly increasing resulting in significant metabolic disorders and complications. Dapagliflozin and sitagliptin have complimentary mechanism of action and have shown synergistic effects in controlling blood glucose levels with advantage of low risk of hypoglycemia. Use of fixed dose combinations (FDC) is associated with improved patient compliance. This is an Age Stratified analysis of electronic medic...

ea0099ep639 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Real-world effectiveness of dapagliflozin and sitagliptin fixed-dose combination in indian patients with type 2 diabetes: a retrospective analysis of electronic medical records stratified by BMI

Kovil Rajiv , Deshmane Rajesh , Bharathi B Prakadeesh , Ahire Prachi , Kudrigikar Vinay , Dharmadhikari Shruti , Khandhedia Chintan , Markandeywar Neeraj , Mane Amey , Mehta Suyog

Introduction and Objective: Escalating prevalence of type 2 diabetes mellitus (T2D) in India presents a significant health challenge. Dapagliflozin and sitagliptin are important treatments for achieving glycaemic control in patients with T2D. Dapagliflozin promotes weight loss benefiting overweight and obese patients, while sitagliptin enhances incretin hormone activity with modest weight loss. This is a BMI-stratified analysis of electronic medical record (EMR) based real wor...